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OBJECTIVES The purpose of this study is to evaluate right ventricular (RV) volume and function after
pulmonary valve replacement (PVR) and to address the issue of optimal surgical timing in
these patients.
BACKGROUND Chronic pulmonary regurgitation (PR) following repair of tetralogy of Fallot (TOF) leads to
RV dilation and an increased incidence of sudden cardiac death in adult patients.
METHODS We studied 25 consecutive adult patients who underwent PVR for significant PR late after
repair of TOF. Radionuclide angiography was performed in all at a mean of 8.2 months (6
8 months) before PVR and repeated at a mean of 28.0 months (6 22.8 months) after the
operation. Right ventricular (RV) end-systolic volume (RVESV), RV end-diastolic volume
(RVEDV) and RV ejection fraction (RVEF) were measured.
RESULTS Mean RVEDV, RVESV and RVEF remained unchanged after PVR (227.1 ml versus 214.9
ml, p 5 0.74; 157.4 ml versus 155.4 ml, p 5 0.94; 35.6% versus 34.7%, p 5 0.78,
respectively). Of the 10 patients with RVEF $ 0.40 before PVR, 5 patients (50%) maintained
a RVEF $ 0.40 following PVR, whereas only 2 out of 15 patients (13%) with pre-operative
values ,0.40 reached an RVEF $ 0.40 postoperatively (p , 0.001).
CONCLUSIONS Right ventricular recovery following PVR for chronic significant pulmonary regurgitation
after repair of TOF may be compromised in the adult population. In order to maintain
adequate RV contractility, pulmonary valve implant in these patients should be considered
before RV function deteriorates. (J Am Coll Cardiol 2000;36:1670–5) © 2000 by the
American College of Cardiology
The hemodynamic effect of long-term left-sided valvular
regurgitation on its recipient chamber is manifest by pro-
gressive left ventricular (LV) dilation with preserved ejec-
tion fraction until irreversible LV pump failure supervenes
(1). The prognosis of medically treated patients with severe,
chronic aortic regurgitation is dismal when the condition is
associated with symptoms, atrial fibrillation, progressive LV
dilation or diminished LV contractility (2,3). The potential
for reversibility of LV dysfunction following aortic valve
replacement depends on pre-operative LV function and
dimension (4–8). Consequently, timing of surgical inter-
vention in such patients, before irreversible contractile
impairment and pump dysfunction supervene, is the essence
of the decision-making process (4–8). Chronic, isolated
severe pulmonary regurgitation (PR) has been shown to
result in right ventricular (RV) dilation (9–11). In adults
with repaired Tetralogy of Fallot (TOF) and chronic PR,
RV dilation has been shown to correlate with an increased
incidence of sudden cardiac death (12,13). Little is known,
however, of the fate of the RV after pulmonary valve
replacement (PVR) in such patients (14–16). The reversible
nature of RV dysfunction remains to be established in these
adults, and the issue of optimal timing for PVR needs to be
addressed. The purpose of this study is to evaluate consec-
utive patients with PVR and to determine their outcome in
reference to pre-operative status.
MATERIALS AND METHODS
Patient population. We conducted a retrospective study
evaluating all consecutive patients older than 18 years of age
who underwent PVR for PR late after repair of TOF and
selected all patients that had a routine rest and exercise
radionuclide angiogram (RNA) test performed at the Uni-
versity of Toronto Congenital Cardiac Center for Adults
before and after PVR. We reviewed and recorded surgical
data including initial palliative procedures, details of repair
and PVR. Clinical status of patients before and after PVR
was ascertained from hospital records. Clinical arrhythmia
was defined as: 1) sustained atrial flutter/fibrillation or
sustained ventricular tachycardia documented on a 12-lead
electrocardiogram (ECG), Holter recording and electrocar-
diographic strips or 2) palpitations associated with syncope
or near syncope in patients subsequently found to have
sustained atrial flutter/fibrillation or ventricular tachycardia
at electrophysiological testing. Sustained arrhythmia was
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defined as arrhythmia lasting .30 s or of any length if
associated with symptoms other than palpitations.
Echocardiographic analysis. Pre-operative and postoper-
ative (most recent) two-dimensional color Doppler and
M-mode echocardiogram reports were reviewed on each
patient. The severity of PR was assessed by pulse-wave
Doppler characteristics and color flow mapping as previ-
ously described (17) and was graded as mild, moderate or
severe. Tricuspid regurgitation was also assessed according
to standard technique. Right ventricular dilation was esti-
mated from RV inlet measurements, made at end-diastole
from apical four-chamber views (18). Right ventricular
enlargement was considered mild when the RV inlet mea-
sured between 40 mm and 50 mm; moderate, between
50 mm and 60 mm; and severe, .60 mm.
Surgical technique. Pulmonary valve replacement was per-
formed through a median sternotomy using standard car-
diopulmonary bypass and mild systemic hypothermia (32°
and 35°C) in all patients. Bioprosthetic pulmonary valves
were sewn into the pulmonary annulus and covered with a
patch of autologous pericardium. The pericardial patch
extended from the pulmonary artery bifurcation onto the
RV infundibulum.
Radionuclide angiogram. Radionuclide angiogram was
performed at rest and maximal exercise before and after
PVR. The patients were radio-labeled with Tc-99m with
standard technique, and the patient was imaged supine
using the standard views, including the best septal view that
optimized separation of the RV from surrounding struc-
tures, including the LV and the left atrium. Right ventric-
ular end-systolic/-diastolic volume (RVESV/RVEDV) and
ejection fraction were calculated using semi-automated edge
detection algorithm by two experienced technologists who
were unaware of the patient’s clinical status. A right ven-
tricular ejection fraction (RVEF) $0.40 was considered
normal (19). Exercise testing was performed on a Quinton
bicycle with gradual increase in the workload every 3 min
until exhaustion or symptom development.
Statistical analysis. We analyzed the data using SPSS for
Windows (version 7.0, SPSS, Chicago, Illinois). Descriptive
data for continuous variables are presented as means 6 SD
or as medians with ranges, when appropriate. Discrete
variables were analyzed by the chi-square or Fisher exact
test. Continuous data were analyzed by the Wilcoxon
rank-sum test. Pairwise analysis of continuous variables was
performed using the Wilcoxon sign-rank test.
RESULTS
Patient population. Four hundred sixty-five patients had
repaired TOF, of which 55 underwent PVR as adults.
Twenty-five patients (14 male and 11 female) had under-
gone rest and exercise RNA before and after PVR. Routine
RNA testing became standard practice at our institution
only during the last five years, explaining the relatively small
percentage. Seventeen patients (68%) had one or more
palliative procedures prior to intracardiac repair, most com-
monly a Blalock–Taussig shunt (52%). Mean age at TOF
repair was 12.1 years (610.6 years, range 4 to 43 years). A
trans-RV approach at the time of repair was used in all
patients, and a transannular patch was used in 44% of the
patients. Indications for PVR were significant pulmonary
regurgitation with either 1) exercise intolerance, 2) progres-
sive RV dilation (identified from serial transthoracic echo-
cardiographic studies), or 3) clinical arrhythmia, with most
patients (56%) fulfilling two or three criteria (Table 1).
Incidence of clinical arrhythmia was 20% in our patients’
cohort. One patient had concomitant moderate/severe RV
outflow tract obstruction (Doppler gradient .50 mm Hg).
PVR. Pulmonary valve replacement was performed at a
mean age of 33.9 years (69.2 years, range 19 to 53 years)
with a mean time from repair to PVR of 21.8 years (68.2
years, range 10 to 36 years). Most patients (96%) received a
xenograft pulmonary valve, the size ranging from 25 to
Abbreviations and Acronyms
LV 5 left ventricular, left ventricle
MRI 5 magnetic resonance imaging
PR 5 pulmonary regurgitation
PVR 5 pulmonary valve replacement
RNA 5 radionuclide angiography, radionuclide
angiogram
RV 5 right ventricular, right ventricle
RVEDV 5 right ventricular end-diastolic volume
RVEF 5 right ventricular ejection fraction
RVESV 5 right ventricular end-systolic volume
RVOT 5 right ventricular outflow tract
TOF 5 Tetralogy of Fallot
Table 1. Demographic and Surgical Characteristics: Total
Cohort of Patients
Variable (n 5 25)
Male gender 14 (56%)
Prior palliation 17 (68%)
BT shunt 13 (52%)
Mean age at initial repair, years 12.1 6 10.6
Mean age at PVR, years 33.9 6 9.2
Mean time from repair, years 21.8 6 8.2
Indication for PVR
Dyspnea 1 RV dilation 10 (40%)
RV dilation 1 arrhythmia 2 (8%)
Dyspnea 1 RV dilation 1 arrhythmia 2 (8%)
Dyspnea alone 6 (24%)
RV Dilation alone 4 (16%)
Arrhythmia alone 1 (4%)
Additional procedure
Aneurysm resection 10 (40%)
Relief of infundibular stenosis 10 (40%)
TV annuloplasty 5 (20%)
ASD closure 4 (16%)
VSD closure 3 (12%)
Atrial cryoablation 3 (12%)
Ventricular cryoablation 3 (12%)
ASD 5 atrial septal defect; BT 5 Blalock Taussig; PVR 5 pulmonary valve
replacement; RV 5 right ventricle; TOF 5 Tetralogy of Fallot; TV 5 tricuspid valve;
VSD 5 ventricular septal defect.
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33 mm. Additional procedures performed at the time of
PVR are listed in Table 1. A total of three atrial and three
ventricular cryoablations were performed concomitantly at
the time of PVR on five patients with pre-operative arrhyth-
mias.
Survival
There was no peri-operative mortality. At the latest
follow-up (mean follow-up time of 2.36 years, 62.24 years)
there was no late death.
Follow up clinical status. FUNCTIONAL AND ECHOCAR-
DIOGRAPHIC DATA. Functional and echocardiographic data
are shown in Table 2. At the latest follow-up (mean of 2.36
years), none of the patients was in functional class III-IV
after PVR, compared with 24% before PVR (p , 0.001).
Transthoracic echocardiography, performed at a mean of
1.9 years after PVR, showed a reduction in the incidence of
moderate-to-severe pulmonary regurgitation as well as tri-
cuspid regurgitation (100% vs. 0%, p , 0.001; 36% vs. 0%,
p , 0.001, respectively).
RADIONUCLIDE ANGIOGRAM. Results of the RNAs are
shown in Table 2. Radionuclide angiograms were per-
formed in all patients within a mean of 8.2 months (68
months) prior to PVR and repeated at a mean of 28.0
months (622.8 months) after the operation. Right ventric-
ular function at rest ranged from 0.12 to 0.57 (mean 0.35 6
0.13) before operation. Following PVR, RVEF did not
change significantly (range 0.08 to 0.65, mean 0.34 6 0.11,
p 5 0.78) (Fig. 1). Change in an individual’s RVEF
compared with its own pre-operative value ranged widely,
from 1.60 to 20.52, with a mean of 0.09 6 0.55. Patients
with right ventricular outflow tract (RVOT) aneurysm had
a mean pre-operative RVEF of 0.38 6 0.13, compared with
a mean pre-operative RVEF of 0.34 6 0.12 in patients
without RVOT aneurysm (p 5 0.39). There was a mean
change in RVEF of 0.05 6 0.36 following concomitant RV
aneurysm repair compared with a mean change in RVEF of
0.12 6 0.65 in patients not needing concomitant aneurys-
mectomy (p 5 0.79). Of the 10 patients (4 patients with
RVOT aneurysm) with an RVEF $0.40 prior to PVR, 5
patients (50%) (3 patients with RVOT aneurysm) main-
tained an ejection fraction $0.40, whereas only 2 out of 15
patients (13%) with pre-operative values ,0.40 reached an
ejection fraction $0.40 postoperatively (p , 0.001).
Before the operation, RVESV at rest ranged from 42 ml
to 449 ml (mean 157.4 ml 6 95.6) and did not change
significantly after PVR (range 54 ml to 553 ml, mean 155.4
ml 6 125.9, p 5 0.94) (Fig. 2). Similarly, after pulmonary
valve implant, RVEDV did not change significantly (mean
227.1 ml 6 119 pre-operatively vs. mean 214.9 ml 6 138
postoperatively, p 5 0.74) (Fig. 3).
Time interval between PVR and postoperative RNA had
no impact on the results. Patients with improvement in
RVEF, RVEDV and RVESV had their test done at a mean
of 1.9 years, 2.4 years and 2.3 years after PVR, whereas
patients showing deterioration in RVEF, RVEDV and
RVESV had their test performed at a mean of 2.6 years, 2.3
years and 2.4 years after PVR (p 5 0.36, 0.87 and 0.92,
respectively).
Correlation between pre-operative echocardiographic
findings and RNA was poor for judging hypokinesis (r 5
–0.47) as well as for quantifying RV dilation (r 5 0.45).
Similarly, there was no correlation between symptomatic
Table 2. Clinical Electrocardiographic and Radionuclide Data Before and After PVR
Variables Pre-PVR Post-PVR p Value
Clinical (n 5 25) (n 5 25)
NYHA III/IV 6 (24%) 0 (0%) , 0.001
Echocardiography (n 5 25) (n 5 25)
PR $ moderate 25 (100%) 0 (0%) , 0.001
TR $ moderate 9 (36%) 0 (0%) , 0.001
RVOTO $50 mmHg 1 (4%) 0 (0%) 0.12
Radionuclide angiogram (n 5 25) (n 5 25)
Mean duration (min) 5.5 6 1.9 5.8 6 2.5 0.38
Mean external workload 476 6 182 440 6 166 0.58
Mean RVEF at rest 0.35 6 0.13 0.34 6 0.11 0.78
Mean RVESV at rest (ml) 157.4 6 95.6 155.4 6 125.9 0.94
Mean RVEDV at rest (ml) 227.1 6 119 214.9 6 138 0.74
NYHA 5 New York Heart Association; PR 5 pulmonary regurgitation; PVR 5 pulmonary valve replacement; RVEDV 5 right
ventricular end-diastolic volume; RVEF 5 right ventricular ejection fraction; RVESV 5 right ventricular end-systolic volume;
RVOTO 5 right ventricular outflow tract obstruction; TR 5 tricuspid regurgitation.
Figure 1. Right ventricular (RV) ejection fraction at rest. Pre-PVR 5
before pulmonary valve replacement, Post-PVR 5 after pulmonary valve
replacement.
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improvement and amelioration of postoperative RV func-
tion (r 5 0.1).
EXERCISE CAPACITY. Measurement of exercise capacity did
not reveal any significant improvement. The mean duration
of exercise pre-operatively was 5.5 min 6 1.9 and 5.8 min
6 2.5 postoperatively (p 5 0.38). Before PVR, patients
achieved a mean maximal external workload (maximal heart
rate 3 maximal systolic blood pressure) of 476 6 182
compared with 440 6 166 following PVR (p 5 0.58)
(Table 2).
DISCUSSION
Pulmonary valve replacement in our study was performed
successfully, with 0% mortality and no recurrence of signif-
icant PR at a mean follow up of 2.36 years. Subjective
improvement in clinical symptoms was also recorded. De-
spite these seemingly encouraging results, however, our data
demonstrate the lack of significant improvement in RV
contractility and dimension following pulmonary valve im-
plant in our adult cohort. Similarly, objective measures of
exercise capacity failed to improve after surgery. The pro-
portion of patients having a normal RV contractility post-
operatively (ejection fraction $0.40) was significantly in-
creased when pre-operative RVEF was $0.40 (p , 0.001).
RNA
The effect of PVR on RV volume and contractility in
children and adolescents with significant pulmonary regur-
gitation late after repaired TOF has been previously studied
(14–16). Bove et al. (15) reported on eight such patients.
Pulmonary valve replacement, performed at a mean age of
14.6 years, resulted in improvement in RVEF as measured
by RNA and a diminution in RV end-diastolic dimension as
measured by M-mode echocardiography. Subjective im-
provement in exercise tolerance was also recorded, but no
objective assessment was performed (15). Warner et al. (16)
reported on 16 patients undergoing PVR at a mean age of
12 years. They recorded a significant reduction of RV
end-diastolic dimension as measured by M-mode echocar-
diography, and some improvement in objective exercise
tolerance in six patients (16). A more recent study by
d’Udekem et al. (14) on 15 patients who underwent PVR at
a median age of 13 years, revealed no significant improve-
ment in RV end-diastolic diameter when measured by RNA
but found a significant decrease in the mean ratio between
the end-diastolic diameter of the RV and LVs. Objective
measurement of exercise capacity was not performed (14).
The data reported from these studies differed from our
findings. We believe that two factors are responsible for
these differences.
Measurement of RV dimension by M-mode echocardi-
ography as reported by Bove et al. (15) and Warner et al.
(16) is highly dependent on image quality and cursor
position. Furthermore, because of the complex geometry of
the RV, the precision and reproducibility of such measure-
ment is highly variable, and consequently, reported results
should be interpreted with caution (20,21). Preliminary data
from another study on 70 adults with repaired TOF
undergoing PVR conducted at our center, showed a signif-
icant decrease in RV dimension after pulmonary valve
implant transthoracic when assessed by echocardiography
(22). Right ventricular dimension, taken from a four-
chamber view, was in retrospect perhaps an over-simplified
way to assess a complex 3D cavity such as the RV (23).
With increasing experience, RNA for evaluation of RVEF
and volume allows better detection and quantification of
impaired RV function and dilation patients (24–27) and has
gained widespread acceptance and application.
When RNA was used by d’Udekem et al. (14) and Bove
et al. (15) to assess RV dimension and contractility after
PVR, positive results were reported (14,15). The patient
population reported by the previous authors, however, was
significantly younger at the time of PVR when compared
with our cohort of adult patients (mean of 13.0 years vs.
33.9 years, respectively). The potential for contractile recov-
ery and ability of the RV to undergo remodeling after PVR
may diminish over time. Perhaps the effect of chronic
cyanosis (28), lack of adequate myocardial protection during
cardiopulmonary bypass and direct myocardial damage from
right ventriculotomy at the time of initial repair (29–31)
Figure 2. Right ventricular (RV) end-systolic volume at rest. Pre-PVR 5
before pulmonary valve replacement, Post-PVR 5 after pulmonary valve
replacement.
Figure 3. Right ventricular (RV) end-diastolic volume at rest. Pre-PVR 5
before pulmonary valve replacement, Post-PVR 5 after pulmonary valve
replacement.
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may impair the ability of the aging RV to recover after
pulmonary valve implant. Alternatively, one may argue that
RV recovery is simply slower in the adult population. This,
however, is rather unlikely considering that LV recovery has
been shown to occur well within one year of surgery in adult
patients undergoing left-sided valvular surgery for chronic
regurgitant lesions (11,32).
EXERCISE CAPACITY
The improvement in clinical symptoms reported by us and
others was not substantiated by objective measurement of
maximal exercise capacity performed in our study. This may
not come as a surprise, as the subjective symptoms may
improve because of a decrease in pulmonary artery pulsatility
and/or change in pulmonary compliance. Objective exercise
improvement, however, is dependent on net change in
forward cardiac output or change in peripheral muscle
conditioning. Furthermore, exercise capacity has been
shown to inversely correlate with RV dilation in patients
with repaired TOF (33). Our exercise results do corroborate
with our RV volumetric data.
CLINICAL IMPLICATIONS
Because RV dilation has been linked to the development of
tachycardia and sudden cardiac death (12,13), it is impera-
tive that we try to prevent or reverse the process of RV
dilation in time. Our study would indicate that if one wishes
to maintain a normal RVEF postoperatively, the optimal
timing of PVR in the adult population may be before the
RV function starts to deteriorate.
STUDY LIMITATIONS
Right ventricular size and contractility remain difficult to
quantitate with precision because of the complex geometry.
Despite its widespread use and acceptance, RNA has some
limitations in the assessment of the RV (34). Magnetic
resonance imaging (MRI) is now emerging as the gold
standard technique to assess RV size and function (35,36),
but data on RV function obtained with this technique were
not available in our patients’ cohort. A second limitation is
the retrospective nature of the data, which did not capture
the entire data set. Potential referral biases cannot be
excluded, although a wide range of ventricular dimension
and performance was represented in our data set. Lastly,
data on VO2 max would have been desirable for a more
complete assessment of objective exercise capacity in our
patients.
CONCLUSIONS
The potential for RV recovery after PVR for chronic
significant PR after repair of TOF may be compromised in
the adult population. In order to maintain adequate RV
contractility, pulmonary valve implant in these patients
should be considered before RV dysfunction ensues. A
multicenter prospective study including MRI and VO2 max
measurements should be conducted, addressing the issue of
optimal timing of PVR in this patient population.
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